Transtympanic STS Against Cisplatin-induced SNHL: the SOUND Trial

Clinical trial NCT07281508 · RECRUITING

Trial details

NCT number: NCT07281508
Sponsor: The Netherlands Cancer Institute
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cisplatin-related Hearing Loss

Start date: 2025-08-14
Primary completion: 2030-03-23
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.